[Treatment of gastric and duodenal ulcers using carbenoxolone sodium. (Double blind trial)]
- PMID: 4559199
[Treatment of gastric and duodenal ulcers using carbenoxolone sodium. (Double blind trial)]
Similar articles
-
Controlled double blind trial of carbenoxolone in gastric and duodenal ulcer.Int J Clin Pharmacol. 1974 Dec;10(4):309-18. Int J Clin Pharmacol. 1974. PMID: 4613674 Clinical Trial. No abstract available.
-
[Plasma renin activity, aldosterone excretion rate, serum electrolytes and blood pressure before and following treatment with carbenoxolone-sodium].Verh Dtsch Ges Inn Med. 1971;77:1008-13. Verh Dtsch Ges Inn Med. 1971. PMID: 5155952 German. No abstract available.
-
Proceedings: A double blind trial of carbenoxolone and geranyl farnesylacetate in gastric ulcer.Gut. 1974 Oct;15(10):833. Gut. 1974. PMID: 4611753 Clinical Trial. No abstract available.
-
Carbenoxolone sodium.Gut. 1968 Feb;9(1):5-6. doi: 10.1136/gut.9.1.5. Gut. 1968. PMID: 4867935 Free PMC article. Review. No abstract available.
-
Carbenoxolone sodium in the treatment of peptic ulcer. A review.JAMA. 1974 Jul 22;229(4):460-2. JAMA. 1974. PMID: 4600402 Review. No abstract available.
Cited by
-
Carbenoxolone: a review of its pharmacological properties and therapeutic efficacy in peptic ulcer disease.Drugs. 1976;11(4):245-307. doi: 10.2165/00003495-197611040-00002. Drugs. 1976. PMID: 780088 Review.
-
Drugs for peptic ulcer.World J Surg. 1979 Sep 20;3(5):659-60. doi: 10.1007/BF01654782. World J Surg. 1979. PMID: 516781 No abstract available.